Cargando…

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease

BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Gaoshi, Chen, Rirong, Jiang, Yueyun, Li, Li, Zheng, Jieqi, Li, Chao, Zhang, Shenghong, Chen, Minhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984852/
https://www.ncbi.nlm.nih.gov/pubmed/35399190
http://dx.doi.org/10.1177/17562848221089096
_version_ 1784682270598103040
author Zhou, Gaoshi
Chen, Rirong
Jiang, Yueyun
Li, Li
Zheng, Jieqi
Li, Chao
Zhang, Shenghong
Chen, Minhu
author_facet Zhou, Gaoshi
Chen, Rirong
Jiang, Yueyun
Li, Li
Zheng, Jieqi
Li, Chao
Zhang, Shenghong
Chen, Minhu
author_sort Zhou, Gaoshi
collection PubMed
description BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic model to identify endoscopic recurrence. METHODS: This was a retrospective cohort study recruiting postoperative CD patients who underwent endoscopy at the First Affiliated Hospital, Sun Yat-sen University from January 2016 to June 2020. Endoscopic recurrence was defined as Rutgeerts score > i1. Thirty non-invasive biomarkers, including C-reactive protein, erythrocyte sedimentation rate, vitamin D, complete blood count, and biochemical blood indices, were used as candidate predictors to build a multivariate logistic regression diagnostic model. The predictive ability of the diagnostic models was assessed by receiving the area under the characteristic curve (AUC) and calibration plots, and internal validation was performed by the bootstrap method. RESULTS: Two hundred and nineteen eligible patients were included in this study, and 135 (61.6%) patients had a postoperative endoscopic recurrence. The final diagnostic model included eight biomarkers with an AUC (95% confidence interval (CI)) of 0.796 (0.737–0.855) to identify endoscopic recurrence. The AUC, sensitivity, and specificity of this diagnostic model were 0.781 (0.780–0.782), 0.647 (0.643–0.651) and 0.811 (0.807–0.815), respectively, by internal validation. In addition, the diagnostic model exhibited good calibrability with calibration slope, calibration-in-the-large (‘mean calibration’) and Brier scores of 1.00, 0.00, and 0.175, respectively. CONCLUSION: This non-invasive biomarker-based diagnostic model has an excellent ability to identify endoscopic recurrence in patients with CD. Application of the model to clinical practice to monitor postoperative patients may be helpful for patient management.
format Online
Article
Text
id pubmed-8984852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-89848522022-04-07 Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease Zhou, Gaoshi Chen, Rirong Jiang, Yueyun Li, Li Zheng, Jieqi Li, Chao Zhang, Shenghong Chen, Minhu Therap Adv Gastroenterol Original Research BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic model to identify endoscopic recurrence. METHODS: This was a retrospective cohort study recruiting postoperative CD patients who underwent endoscopy at the First Affiliated Hospital, Sun Yat-sen University from January 2016 to June 2020. Endoscopic recurrence was defined as Rutgeerts score > i1. Thirty non-invasive biomarkers, including C-reactive protein, erythrocyte sedimentation rate, vitamin D, complete blood count, and biochemical blood indices, were used as candidate predictors to build a multivariate logistic regression diagnostic model. The predictive ability of the diagnostic models was assessed by receiving the area under the characteristic curve (AUC) and calibration plots, and internal validation was performed by the bootstrap method. RESULTS: Two hundred and nineteen eligible patients were included in this study, and 135 (61.6%) patients had a postoperative endoscopic recurrence. The final diagnostic model included eight biomarkers with an AUC (95% confidence interval (CI)) of 0.796 (0.737–0.855) to identify endoscopic recurrence. The AUC, sensitivity, and specificity of this diagnostic model were 0.781 (0.780–0.782), 0.647 (0.643–0.651) and 0.811 (0.807–0.815), respectively, by internal validation. In addition, the diagnostic model exhibited good calibrability with calibration slope, calibration-in-the-large (‘mean calibration’) and Brier scores of 1.00, 0.00, and 0.175, respectively. CONCLUSION: This non-invasive biomarker-based diagnostic model has an excellent ability to identify endoscopic recurrence in patients with CD. Application of the model to clinical practice to monitor postoperative patients may be helpful for patient management. SAGE Publications 2022-04-04 /pmc/articles/PMC8984852/ /pubmed/35399190 http://dx.doi.org/10.1177/17562848221089096 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Zhou, Gaoshi
Chen, Rirong
Jiang, Yueyun
Li, Li
Zheng, Jieqi
Li, Chao
Zhang, Shenghong
Chen, Minhu
Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
title Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
title_full Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
title_fullStr Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
title_full_unstemmed Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
title_short Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease
title_sort development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of crohn’s disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984852/
https://www.ncbi.nlm.nih.gov/pubmed/35399190
http://dx.doi.org/10.1177/17562848221089096
work_keys_str_mv AT zhougaoshi developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT chenrirong developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT jiangyueyun developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT lili developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT zhengjieqi developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT lichao developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT zhangshenghong developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease
AT chenminhu developmentandvalidationofanoninvasivebiomarkerbasedmodeltoidentifyendoscopicrecurrencesofcrohnsdisease